Is CRSA or JNJ a better dividend investment in 2026?

CRSA currently yields 22.70% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CRSA offers higher current income.

What is the dividend yield difference between CRSA and JNJ?

CRSA has a forward dividend yield of 22.70% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 19.34 percentage points.

Home › Compare › CRSA vs JNJ

CRSA vs JNJ: Dividend Comparison 2026

CRSA yields 22.70% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRSA wins by $66.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRSA

● Live price

22.70%

Share price

$8.81

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$86.1K

Annual income

$8,904.16

Full CRSA calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CRSA vs JNJ

📍 CRSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRSA	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRSA + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRSA pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRSA

Annual income on $10K today (after 15% tax)

$1,929.63/yr

After 10yr DRIP, annual income (after tax)

$7,568.54/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CRSA beats the other by $6,864.92/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRSA + JNJ for your $10,000?

CRSA: 50%JNJ: 50%

100% JNJ50/50100% CRSA

Portfolio after 10yr

$53.0K

Annual income

$4,865.97/yr

Blended yield

9.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CRSA

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRSA buys

JNJ buys

No recent congressional trades found for CRSA or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRSAJNJ

Forward yield	22.70% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$86.1K ✓	$20.0K
Annual income after 10y	$8,904.16 ✓	$827.78
Total dividends collected	$52.1K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CRSA vs JNJ ($10,000, DRIP)

Year	CRSA Portfolio	CRSA Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,970	$2,270.15	$10,676	$355.77	+$2.3K → CRSA
2	$16,630	$2,751.79	$11,407	$389.39	+$5.2K → CRSA
3	$21,091	$3,297.42	$12,198	$426.53	+$8.9K → CRSA
4	$26,476	$3,908.48	$13,056	$467.62	+$13.4K → CRSA
5	$32,915	$4,585.38	$13,987	$513.12	+$18.9K → CRSA
6	$40,547	$5,327.56	$14,998	$563.56	+$25.5K → CRSA
7	$49,518	$6,133.46	$16,098	$619.52	+$33.4K → CRSA
8	$59,985	$7,000.56	$17,295	$681.69	+$42.7K → CRSA
9	$72,110	$7,925.51	$18,599	$750.82	+$53.5K → CRSA
10	$86,061	$8,904.16	$20,022	$827.78	+$66.0K → CRSA

CRSA vs JNJ: Complete Analysis 2026

CRSA — Stock

Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Crescent Funding Inc. and changed its name to Crescent Acquisition Corp. in October 2018. The company was founded in 2017 and is based in Los Angeles, California.

Full CRSA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CRSA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRSA vs SCHD CRSA vs JEPI CRSA vs O CRSA vs KO CRSA vs MAIN CRSA vs ABBV CRSA vs MRK CRSA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.